Firefly Neuroscience, Inc. (AIFF)
NASDAQ: AIFF · Real-Time Price · USD
1.070
+0.010 (0.94%)
Sep 10, 2026, 4:00 PM EDT - Market closed
Firefly Neuroscience Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1.8 | 1.14 | 0.11 | 0.5 | - | 0.03 | |
Revenue Growth | 320.33% | 957.41% | -78.31% | - | - | - |
Cost of Revenue | 1 | 0.5 | - | - | - | - |
Gross Profit | 0.8 | 0.65 | 0.11 | 0.5 | - | 0.03 |
Selling, General & Admin | 7.86 | 7.72 | 7.33 | 2.84 | 2.07 | 1.76 |
Research & Development | 1.78 | 1.48 | 1.95 | 0.74 | 1.3 | 2.93 |
Operating Expenses | 9.64 | 9.2 | 9.29 | 3.58 | 3.37 | 4.69 |
Operating Income | -8.84 | -8.56 | -9.18 | -3.08 | -3.37 | -4.65 |
Interest Expense | -0.03 | -0.16 | -0.07 | -0.02 | -0.44 | -0.14 |
Interest & Investment Income | 0.11 | 0.09 | - | - | - | - |
Currency Exchange Gain (Loss) | -0 | -0.01 | 0.01 | 0.04 | -0.13 | - |
Other Non Operating Income (Expenses) | -0.05 | -9.59 | -0.35 | 0.46 | 0.01 | -0 |
EBT Excluding Unusual Items | -8.81 | -18.22 | -9.58 | -2.6 | -3.93 | -4.79 |
Merger & Restructuring Charges | -0.05 | -0.05 | - | - | - | - |
Gain (Loss) on Sale of Investments | - | - | - | - | - | 0.55 |
Gain (Loss) on Sale of Assets | - | - | - | - | 0.17 | 0.31 |
Asset Writedown | -0.25 | -0.25 | -0.87 | - | -0.08 | - |
Other Unusual Items | - | -1.35 | - | - | -0.06 | -0.45 |
Pretax Income | -9.11 | -19.88 | -10.46 | -2.6 | -3.9 | -4.38 |
Income Tax Expense | 0 | 0.01 | 0 | 0 | - | - |
Net Income | -9.11 | -19.88 | -10.46 | -2.6 | -3.9 | -4.38 |
Preferred Dividends & Other Adjustments | 0.33 | 4.65 | - | - | - | - |
Net Income to Common | -9.44 | -24.53 | -10.46 | -2.6 | -3.9 | -4.38 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 16 | 12 | 7 | 3 | 1 | - |
Shares Outstanding (Diluted) | 16 | 12 | 7 | 3 | 1 | - |
Shares Change | 62.62% | 90.07% | 102.48% | 134.29% | - | - |
EPS (Basic) | -0.60 | -1.97 | -1.60 | -0.81 | -2.83 | - |
EPS (Diluted) | -0.60 | -1.97 | -1.60 | -0.81 | -2.83 | - |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.2 | -8.32 | -6.3 | -2.17 | -2.89 | -3.82 |
Free Cash Flow Per Share | -0.46 | -0.67 | -0.96 | -0.67 | -2.10 | - |
Gross Margin | 44.58% | 56.48% | 100.00% | 100.00% | - | 100.00% |
Operating Margin | -491.38% | -749.12% | -8500.00% | -618.07% | - | -14543.75% |
Profit Margin | -524.51% | -2148.07% | -9685.18% | -522.69% | - | -13690.63% |
Free Cash Flow Margin | -400.22% | -728.72% | -5836.11% | -436.14% | - | -11937.50% |
EBITDA | -8.72 | -8.46 | -9.17 | -3.06 | -3.35 | -4.23 |
D&A For EBITDA | 0.12 | 0.09 | 0.01 | 0.01 | 0.01 | 0.43 |
EBIT | -8.84 | -8.56 | -9.18 | -3.08 | -3.37 | -4.65 |